Pre-pregnancy complications - associated factors and wellbeing in early pregnancy: a Swedish cohort study.

Artificial reproductive technologies Early pregnancy Fertility Late miscarriage Pre-pregnancy Pregnancy symptoms Recurrent pregnancy loss Subfertility

Journal

BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799

Informations de publication

Date de publication:
08 Mar 2023
Historique:
received: 08 11 2022
accepted: 01 03 2023
entrez: 8 3 2023
pubmed: 9 3 2023
medline: 11 3 2023
Statut: epublish

Résumé

Many couples experience difficulties to become pregnant or carry a pregnancy to term due to unknown causes. Here we define pre-pregnancy complications as having prior recurrent pregnancy loss, prior late miscarriages, time to pregnancy more than one year, or the use of artificial reproductive technologies. We aim to identify factors associated with pre-pregnancy complications and poor well-being in early pregnancy. Online questionnaire data from 5330 unique pregnancies in Sweden were collected from November 2017 - February 2021. Multivariable logistic regression modelling was used to investigate potential risk factors for pre-pregnancy complications and differences in early pregnancy symptoms. Pre-pregnancy complications were identified in 1142 participants (21%). Risk factors included diagnosed endometriosis, thyroid medication, opioids and other strong pain medication, body mass index > 25 kg/m We report one of the largest pregnancy cohorts with high frequency of pre-pregnancy complications compared to the Swedish population. Prescribed drug use and body weight were the top potentially modifiable risk factors in all groups. Participants that experienced pre-pregnancy complications also had higher risk of depression and pregnancy problems in early pregnancy.

Sections du résumé

BACKGROUND BACKGROUND
Many couples experience difficulties to become pregnant or carry a pregnancy to term due to unknown causes. Here we define pre-pregnancy complications as having prior recurrent pregnancy loss, prior late miscarriages, time to pregnancy more than one year, or the use of artificial reproductive technologies. We aim to identify factors associated with pre-pregnancy complications and poor well-being in early pregnancy.
METHODS METHODS
Online questionnaire data from 5330 unique pregnancies in Sweden were collected from November 2017 - February 2021. Multivariable logistic regression modelling was used to investigate potential risk factors for pre-pregnancy complications and differences in early pregnancy symptoms.
RESULTS RESULTS
Pre-pregnancy complications were identified in 1142 participants (21%). Risk factors included diagnosed endometriosis, thyroid medication, opioids and other strong pain medication, body mass index > 25 kg/m
CONCLUSION CONCLUSIONS
We report one of the largest pregnancy cohorts with high frequency of pre-pregnancy complications compared to the Swedish population. Prescribed drug use and body weight were the top potentially modifiable risk factors in all groups. Participants that experienced pre-pregnancy complications also had higher risk of depression and pregnancy problems in early pregnancy.

Identifiants

pubmed: 36890460
doi: 10.1186/s12884-023-05479-8
pii: 10.1186/s12884-023-05479-8
pmc: PMC9993650
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

153

Informations de copyright

© 2023. The Author(s).

Références

Prog Urol. 2014 Sep;24(11):708-13
pubmed: 25214452
Lancet. 2002 Jul 13;360(9327):151-9
pubmed: 12126838
Exp Ther Med. 2021 Apr;21(4):306
pubmed: 33717249
Am J Obstet Gynecol. 2014 Oct;211(4):358.e1-6
pubmed: 24799313
Healthcare (Basel). 2021 Apr 15;9(4):
pubmed: 33920767
J Clin Pathol. 2019 Sep;72(9):579-587
pubmed: 31296604
Nat Rev Dis Primers. 2019 Jan 24;5(1):7
pubmed: 30679436
Clin Biochem. 2018 Dec;62:2-10
pubmed: 29555319
BMJ Open. 2022 Oct 26;12(10):e065825
pubmed: 36288838
Nat Rev Dis Primers. 2020 Dec 10;6(1):98
pubmed: 33303732
J Clin Endocrinol Metab. 1961 Nov;21:1440-7
pubmed: 13892577
J Health Soc Behav. 1983 Dec;24(4):385-96
pubmed: 6668417
Am J Obstet Gynecol. 2019 Apr;220(4):354.e1-354.e12
pubmed: 30625295
Science. 2016 Apr 29;352(6285):565-9
pubmed: 27126040
Best Pract Res Clin Endocrinol Metab. 2019 Feb;33(1):127-132
pubmed: 31130446
Br J Psychiatry. 1987 Jun;150:782-6
pubmed: 3651732
Int J Environ Res Public Health. 2018 Nov 20;15(11):
pubmed: 30463276
J Obstet Gynaecol Can. 2009 Sep;31(9):803-807
pubmed: 19941704
BMJ. 2014 Mar 19;348:g1752
pubmed: 24647161
Science. 2016 Apr 29;352(6285):560-4
pubmed: 27126039
Hum Reprod. 2005 May;20(5):1144-7
pubmed: 15802321

Auteurs

Unnur Gudnadottir (U)

Centre for Translational Microbiome Research, Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, 171 65, Solna, Sweden. unnur.gudnadottir@ki.se.

Juan Du (J)

Centre for Translational Microbiome Research, Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, 171 65, Solna, Sweden.

Luisa W Hugerth (LW)

Centre for Translational Microbiome Research, Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, 171 65, Solna, Sweden.
Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.

Lars Engstrand (L)

Centre for Translational Microbiome Research, Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, 171 65, Solna, Sweden.

Ina Schuppe-Koistinen (I)

Centre for Translational Microbiome Research, Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, 171 65, Solna, Sweden.
Science for Life Laboratory, 171 65, Solna, Sweden.

Eva Wiberg Itzel (E)

Department of Clinical Science and Education, Södersjukhuset, Stockholm, Sweden.

Emma Fransson (E)

Centre for Translational Microbiome Research, Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, 171 65, Solna, Sweden.
Department of Women's and Children's health, Uppsala University, 751 85, Uppsala, Sweden.

Nele Brusselaers (N)

Centre for Translational Microbiome Research, Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, 171 65, Solna, Sweden.
Global Health Institute, University of Antwerp, 2610, Antwerp, Belgium.
Department of Head and Skin, Ghent University, 9000, Ghent, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH